holding in moore v regents

Rptr. "Unlimited discretion in the physician is irreconcilable with the basic right of the patient to make the ultimate informed decision...." (Id., at p. By its terms, section 7054.4 permits only "scientific use" of excised body parts and tissue before they must be destroyed. We must therefore determine the usual and ordinary meaning of that phrase. As the majority persuasively explains, because a physician's research activities and related commercial ventures may potentially affect his or her professional judgment, a physician has an obligation to disclose such personal interests to his patient. Third, in soliciting the patient's consent, a physician has a fiduciary duty to disclose all information material to the patient's decision. To achieve this end the originator of the tissue sample first determines the extent of the source's informed consent to its use — e.g., for research only, or for public but academic use, or for specific or general commercial purposes; he then enters this information in the record of the tissue sample, and the record accompanies the sample into the hands of any researcher who thereafter undertakes to work with it. 34.). (Cobbs v. Grant, supra, 8 Cal.3d at p. (7) "To establish a conversion, plaintiff must establish an actual interference with his ownership or right of possession. opn., ante, p. Even if this is an accurate statement of federal patent law, it does not explain why plaintiff may not maintain a conversion action for defendants' unauthorized use of his own body parts, blood, blood serum, bone marrow, and sperm. 191, 218-219. Code, § 66500.) However, neither Golde nor Quan informed Moore of their plans to conduct this research or requested his permission. [35] Federal law permits the patenting of organisms [142] that represent the product of "human ingenuity," but not naturally occurring organisms. (Note, Source Compensation, supra, 64 Notre Dame L. Rev. (Howard, Biotechnology, Patients' Rights, and the Moore Case (1989) 44 Food Drug Cosm. To date, however, the Legislature has not adopted such a system for organs that are to be used for [160] research or commercial purposes,[51] and the majority opinion, despite some oblique suggestions to the contrary (see maj. California -. Rptr. If the Regents, in the first instance, has the power to register institutions "in terms of New York standards" (Education Law, § 210), and the power to suspend the rights and privileges of an institution violating "any rule or law of the university" (Education Law, § 215), it would not appear unreasonable to conclude that the Regents also possesses the power to deny the registration of doctoral degree programs which it believes do not conform with standards set for institutions of higher education. 241.) (Ed. Contrary to the implication of the majority's assertion, it requires no extension of existing common law principles to recognize that a conversion action will lie where the facts alleged in a complaint demonstrate that the defendant obtained the plaintiff's consent by fraud. App.3d 143, 149 [149 Cal. The application of these principles to the present case is evident. (4c) Since Moore clearly did not expect to retain possession of his cells following their removal,[20] to sue for their conversion he must have retained [137] an ownership interest in them. ), It can be extremely difficult to identify the gene that carries the code for a particular lymphokine. at p. Moore v Regentes de la Universidad de. App.3d 593, 610-611 [176 Cal. (4a) Moore also attempts to characterize the invasion of his rights as a conversion — a tort that protects against interference with possessory and ownership interests in personal property. Presently, researchers need only ask for tissue samples, and their requests are usually granted by their own research facility, other research facilities, or tissue banks." [35] The distinction between primary cells (cells taken directly from the body) and patented cell lines is not purely a legal one. This is because in many cases the potential benefits of the treatment to the plaintiff clearly outweigh the undisclosed risk of harm. Mosk J: "Neither is In view, however, of the specific powers granted by the Legislature to the Regents previously discussed, we believe that, in the present case, section 207 operates as a means for the effectuation of independent powers, rather than as their source. (We shall at times refer We do not find this surprising, since the laws governing such things as human tissues,[21] transplantable organs,[22] blood,[23] fetuses,[24] pituitary glands,[25] corneal tissue,[26] and dead bodies[27] deal with human biological materials as objects sui generis, regulating their disposition to achieve policy goals rather than abandoning them to the general law of personal property. 817, 621 P.2d 856]). (Dis. ), The cell line in this case, for example, after many replications began to generate defective and rearranged forms of the HTLV-II virus. 162, 690 P.2d 635], we held inadmissible the testimony of a witness who has undergone hypnosis for the purpose of restoring his memory of the events in issue. As will appear, I do not believe section 7054.4 supports the just quoted conclusion of the majority. (Id. Scientists in practice have been buying and selling human tissues for research apparently without interference from these statutes." There is, however, no need to create a new cause of action. 309-310.) He asks much. 34.) It is precisely because everyone needs the same basic proteins that proteins produced by one person's cells may have therapeutic value for another person. (Prosser & Keeton, Torts (5th ed. [28] One line of cases involves unwanted publicity. (Doers v. Golden Gate Bridge etc. 76.) It is true, that this court has not often been deterred from deciding difficult legal issues simply because they require a choice between competing social or economic policies. In this case, by comparison, limiting the expansion of liability under a conversion theory will only make it more difficult for Moore to recover a highly theoretical windfall. John Moore sought treatment from UCLA Medical Center (defendant) for hairy-cell leukemia. (8A, West's U. Moore v. 180.). It extends to every species of right and interest capable of being enjoyed as such upon which it is practicable to place a money value.'" Moore v. Regents of the University of California (51 Cal. App.2d 124, 132 [57 Cal. opn., ante, p. 134, fn. 52.) (OTA Rep., supra, at p. 498.) We note that Sandoz did not present this argument to the lower courts. MOORE V. REGENTS OF UCLA INTRODUCTION Until recently, severed tissue had no market value.' (See ante, pp. 2, 29, 30, 33 and 35, and text at pp. opn., ante, pp. P consented. [52] Moore thereafter alleges that "he is the owner of his Blood and Bodily Substances and of the by-products produced therefrom...." And he further alleges that such blood and bodily substances "are his tangible personal property, and the activities of the defendants as set forth herein constitute a substantial interference with plaintiff's possession or right thereto, as well as defendants' wrongful exercise of dominion over plaintiff's personal property rights in his Blood and Bodily Substances.". Rules of Court, rules 4 through 5.2.) (Toward the Right of Commerciality, supra, 34 UCLA L.Rev. In contrast to Golde, none of these defendants stood in a fiduciary relationship with Moore or had the duty to obtain Moore's informed consent to medical procedures. 27. (Id.) Introduction. T-lymphocytes produce lymphokines, or proteins that regulate the immune system. (Maj. 1985) Pleading, § 654, p. 103), it is well established that a complaint's contentions or conclusions of law do not bind us. Mr. Moore appealed the demurrers and on July 21, 1988, the court of appeal reversed both lower courts. The act does not, however, permit the donor to receive "valuable consideration" for the transfer. The o 377, § 2, p. 744, and amended by Stats. (OTA Rep., supra, at p. 204-208): "One of the most serious fears associated with university-industry cooperative research concerns keeping work private and not disclosing it to the researcher's peers. (Sears, Roebuck & Co. v. Stiffel Co. (1964) 376 U.S. 225, 231 [11 L.Ed.2d 661, 667, 84 S.Ct. )[68] Secrecy as a normal business practice is also taking hold in university research laboratories, often because of industry pressure (id. [131] Golde argues that the scientific use of cells that have already been removed cannot possibly affect the patient's medical interests. ), [18] Moore alleges, for example, that "genetic sequences ... are his tangible personal property...." We are not, however, bound by that conclusion of law. This time when Moore … (See Danforth, Cells, Sales, & Royalties: The Patient's Right to a Portion of the Profits (1988) 6 Yale L. & Pol'y Rev. at p. [78] And the [182] majority further note that the trial court has already ruled insufficient the allegations of agency as to the corporate defendants. We need not, however, make an arbitrary choice between liability and nonliability. By the same token, however, there is no reported judicial decision that rejects such a claim. opn., ante, p. John MOORE, Plaintiff and Appellant, v. The REGENTS OF THE UNIVERSITY OF CALIFORNIA et al., ... a physician who attended Moore at UCLA Medical Center; (2) the Regents of the University of California (Regents), ... holding that the complaint did state a cause of action for conversion. (Daar v. Yellow Cab Co. (1967) 67 Cal.2d 695, 713 [63 Cal. It is this inventive effort that patent law rewards, not the discovery of naturally occurring raw materials. It is true that the quoted language of the complaint alleges the fact of agency in general terms, but that is the proper form of such an allegation. 141.) But in neither opinion did the authoring court expressly base its holding on property law. Defendants certainly believe that their right to do the foregoing is not barred by section 7054.4 and is a significant property right, as they have demonstrated by their deliberate concealment from Moore of the true value of his tissue, their efforts to obtain a patent on the Mo cell line, their contractual agreements to exploit this material, their exclusion of Moore from any participation in the profits, and their vigorous defense of this lawsuit. Moreover, as already mentioned, the genetic code for lymphokines does not vary from individual to individual. It follows that the statutes regulating the transfers of human organs and blood do not support the majority's refusal to recognize a conversion cause of action for commercial exploitation of human blood cells without consent. opn., ante, p. 136.) (1976) 62 Cal. Given the novel scientific setting in which this case arises and the considerable interest this litigation has engendered within the medical research community and the public generally, it is easy to lose sight of the fact that the specific allegations on which the complaint in this case rests are quite unusual, setting this matter apart from the great majority of instances in which donated organs or cells provide the raw materials for the advancement of medical science and the development of new and beneficial medical products. 31.) Plaintiff alleges that his physician failed to disclose preexisting research and economic interests in the cells before obtaining consent to the medical procedures by which they were extracted. 167]; Berkey v. Anderson (1969) 1 Cal. Moore's T-lymphocytes were interesting to the defendants because they overproduced certain lymphokines, thus making the corresponding genetic material easier to identify. The majority impliedly hold these allegations insufficient as a matter of law, finding three "reasons to doubt" that Moore retained a sufficient ownership interest in his cells, after their excision, to support a conversion cause of action. Moore v. Regents of the Univ. Jul 9, 1990.] 137.) of Mosk, J., post, at p. But he does fall within the spirit of that law: "The joint invention provision guarantees that all who contribute in a substantial way to a product's development benefit from the reward that the product brings. ), Secondly, to the extent that cell cultures and cell lines may still be "freely exchanged," e.g., for purely research purposes, it does not follow that the researcher who obtains such material must necessarily remain ignorant of any limitations on its use: by means of appropriate recordkeeping, the researcher can be assured that the source of the material has consented to his proposed use of it, and hence that such use is not a conversion. (Maj. (Toward the Right of Commerciality, supra, 34 UCLA L.Rev. ), [77] Again the rule is general: "the vast majority of jurisdictions that have considered the issue apply an objective standard," focusing "on what a reasonable patient in the plaintiff's position would have done if adequately informed." I disagree with this conclusion for all the reasons [161] stated by the Court of Appeal, and for additional reasons that I shall explain. By restricting how excised cells may be [141] used and requiring their eventual destruction, the statute eliminates so many of the rights ordinarily attached to property that one cannot simply assume that what is left amounts to "property" or "ownership" for purposes of conversion law. In this context the court in Bouvia wrote that "`[e]very human being of adult years and sound mind has a right to determine what shall be done with his own body....'" (Id., at p. 1139, quoting from Schloendorff v. New York Hospital, supra, 211 N.Y. 125 [105 N.E. I write separately to give voice to a concern that I believe informs much of that opinion but finds little or no expression therein. For present purposes no distinction can be drawn between Moore's cells and the Mo cell line. [31] Schloendorff v. New York Hospital, supra, is often cited as the first opinion recognizing the concept of informed consent. Moore v. Regents of the University of California. (See 11 U.S.C. You can access the new platform at https://opencasebook.org. Rptr. In a unanimous opinion that I authored for the court, we considered inter alia whether pharmaceutical manufacturers should be held strictly liable for injuries caused by "defectively designed" prescription drugs. Although we cited certain psychological literature, the case is likewise distinguishable. (U.S. Patent No. But, as already discussed, Moore clearly alleges that Golde had developed a research interest in his cells by October 20, 1976, when the splenectomy was performed. at p. 621). (Ibid.). If a physician has no plans to conduct research on a patient's cells at the time he recommends the medical procedure by which they are taken, then the patient's medical interests have not been impaired. As we have already discussed, the existence of a motivation for a medical procedure unrelated to the patient's health is a potential conflict of interest and a fact material to the patient's decision. 824], italics added. S006987. Plaintiff alleges that his physician failed to disclose preexisting research and economic interests in the cells before obtaining consent to the medical procedures by which they were extracted. Elisabeth L. Moore et al., Individually and as Trustees of the State University of New York, et al., Appellants, and United University Professions, Inc., Intervenor-Plaintiff, (Dis. Dr. Lawrence Moore’s (Defendant’s) mentally disturbed patient killed Tatiana Tarasoff (Tarasoff). As far as I know, no member of this court is trained as a molecular biologist, or even as a physician; without expert testimony in the record, therefore, the majority are not competent to explain these arcane points of medical science any more than a doctor would be competent to explain esoteric questions of the law of negotiable [184] instruments or federal income taxation, or the rule against perpetuities. 1976), was a case in which the Supreme Court of California held that mental health professionals have a duty to protect individuals who are being threatened with bodily harm by a patient. Code, §§ 654, 655.) "As a general rule, documents not before the trial court cannot be included as a part of the record on appeal." 242.) App.3d 623, 635 [178 Cal. [64] Perhaps the answer lies in an analogy to the concept of "joint inventor." (Maj. Other cell lines have been in wide use since as early as 1951. 1 (hereafter Note, Source Compensation); see also OTA Rep., supra, at pp. 42.) Moore, adopting the analogy originally advanced by the Court of Appeal, argues that "[i]f the courts have found a sufficient proprietary interest in one's persona, how could one not have a right in one's own genetic material, something far more profoundly the essence of one's human uniqueness than a name or a face?" If you would like access to the new version of the H2O platform and have not already been contacted by a member of our team, please contact us at h2o@cyber.law.harvard.edu. With the advent of the State University of New York (L 1948, ch 695 [Education Law, § 352]), however, the Regents became enmeshed in the day-to-day operation of this semi-independent educational corporation. In dictum, the Venner court observed that "[i]t is not unknown for a person to assert a continuing right of ownership, dominion, or control, for good reason or for no reason, over such things as excrement, fluid waste, secretions, hair, fingernails, toenails, blood, and organs or other parts of the body...." (354 A.2d at p. Rptr. Even if the cells of the Mo cell line in fact have an abnormal number of chromosomes, at the present stage of this case we do not know if that fact has any bearing whatever on their capacity to produce proteins; yet it is in the commercial exploitation of that capacity — not simply in their number of chromosomes — that Moore seeks to assert an interest. We value too much our team and our customers and this way, we manage to be one of the most appreciated companies in the Warehousing & Storage by Mosk, J. Rptr. As a general matter, the tort of conversion protects an individual not only against improper interference with the right of possession of his property but also against unauthorized use of his property or improper interference with his right to control the use of his property. Under Education Code section 92040, "[t]he Regents ... may acquire by eminent domain any property necessary to carry out any of the powers or functions of the University of California." 164-165.) Presently, biotechnology allows only the manipulation, not the creation, of life. Moore v. Regents of the University of California enshrined a principle in property law that haunts us to this day: patients have virtually no property interest in most of the non-reproductive cells or tissues taken from them, even when these materials turn … 4,438,032 (Mar. Thus defendants herein recited in their patent specification, "At no time has the Mo cell line been available to other than the investigators involved with its initial discovery and only the conditioned medium from the cell line has been made available to a limited number of investigators for collaborative work with the original discoverers of the Mo cell line. § 274e.) Rptr. A leading decision of this court approved the following definition: "`The term "property" is sufficiently comprehensive to include every species of estate, real and personal, and everything which one person can own and transfer to another. 1987) p. 967; see also OTA Rep., supra, at p. (Maj. Reversing the words of the old song, the nondisclosure cause of action thus accentuates the negative and eliminates the positive: the patient can say no, but he cannot say yes and expect to share in the proceeds of his contribution. If the scientific users of human cells are to be held liable for failing to investigate the consensual pedigree of their raw materials, we believe the Legislature should make that decision. To hold otherwise would open the door to a massive invasion of human privacy and dignity in the name of medical progress." at p. 544, fn. The complaint alleges that Moore's cells naturally produced certain valuable proteins in larger than normal quantities; indeed, that was why defendants were eager to culture them in the first place. Finally, the complaint alleges in detail the contractual arrangements between the foregoing defendants and defendants Genetics Institute, Inc., and Sandoz Pharmaceuticals Corporation, giving the latter companies exclusive rights to exploit that commercial potential while providing substantial financial benefits to the individual defendants in the form of cash, stock options, consulting fees, and fringe benefits. By analogy, we have not required disclosure of "remote" risks (Cobbs v. Grant, supra, 8 Cal.3d at p. 245) that "are not central to the decision to administer or reject [a] procedure." The majority claim that "Moore relies ... primarily" on an analogy to certain right-of-privacy decisions (maj. [70] In a footnote at this point the cited article reports published estimates of the market for biotechnological products, by the end of this decade, ranging from $15 billion to $100 billion. Section 210 must not be read in isolation, but with an awareness of the full range of powers granted to the Regents. On the contrary, the Legislature sought merely to place the State University on the same footing as private institutions of higher education in New York: that is to grant the trustees of the State University the same power to govern the day-to-day operations of the State University as trustees of private institutions possessed. On the contrary, because such statutes treat both organs and blood as property that can legally be sold in a variety of circumstances, they impliedly support Moore's contention that his blood cells are likewise property for which he can and should receive compensation, and hence are protected by the law of conversion. opn., ante, fn. (Magan Medical Clinic v. Cal. Its function is one of an overseer: a body possessed of broad policy-making attributes. These principles lead to the following conclusions: (1) a physician must disclose personal interests unrelated to the patient's health, whether research or economic, that may affect the physician's professional judgment; and (2) a physician's failure to disclose such interests may give rise to a cause of action for performing medical procedures without informed consent or breach of fiduciary duty. The court held that the defendant had abandoned his excrement for purposes of the Fourth Amendment. "Long-term growth of human cells and tissues is difficult, often an art," and the probability of succeeding with any given cell sample is low, except for a few types of cells not involved in this case. 245. See fn. He urges us to commingle the sacred with the profane. Even if rental of the property is a permitted use, rent control laws may limit the benefits of that use. Since biological products of genetic engineering became patentable in 1980 (Diamond v. Chakrabarty [171] (1980) 447 U.S. 303 [65 L.Ed.2d 144, 100 S.Ct. App.3d 606 [109 Cal. 415 20th St, Oakland, 94612. Business to Client (B2C) The Regents Of The University Of California is a B2C company, that has been known in the Educational Services field as one of the best partners in business. What is the Holding of Moore v. Regents? Rptr. (OTA Rep., supra, at pp. In contrast to Brown, therefore, here the harm is by no means "unavoidable." opn., ante, p. 141. To state a conversion cause of action a plaintiff must allege his "ownership or right to possession of the property at the time of the conversion" (Baldwin v. Marina City Properties, Inc. (1978) 79 Cal. Supreme Court of California. If a hospital, after removing an organ from such a donor, decided on its own to give the organ to a different donee, no one would deny that the hospital had violated the legal right of the donor by its unauthorized use of the donated organ. Second, and more generally, in this context — unlike in the traditional "informed consent" context of Cobbs v. Grant (1972) 8 Cal.3d 229 [104 Cal. 25.) (a)), and does not extend its prohibition to purchases or sales of body parts for the other purposes authorized by the statute, i.e., for research, education, or the advancement of medical science. the technology 335 iii. ), [2] A T-lymphocyte is a type of white blood cell. 368-369). 14 (Cal. 3d 120; 271 Cal. Given the current provisions of the Uniform Anatomical Gift Act, there is no basis to conclude that there is a general public policy in this state prohibiting hospitals or medical centers from giving, or prohibiting patients from receiving, valuable consideration for body parts which are to be used for medical research or the advancement of medical science. Finally, there is no pressing need to impose a judicially created rule of strict liability, since enforcement of physicians' disclosure obligations will protect patients against the very type of harm with which Moore was threatened. For several reasons, the inclusion of most of that material in an opinion of this court is improper. 1986) § 2.34, p. 234. Rules of Court, rule 29.3). 71.) Genetics Institute and Sandoz, for example, are not physicians, and the complaint specifically alleges that neither entity became involved until years later. Moore was advised to undergo surgery to remove his spleen. These allegations, in our view, state a cause of action against Golde for invading a [129] legally protected interest of his patient. 505.). Panelli J: “Nor is it necessary to force the round pegs of “privacy” and “dignity” into the square hole of “property” in order to protect the patient". (Lugosi v. Universal Pictures, supra, 25 Cal.3d at pp. The majority then offer a dual explanation: "This is because the patented cell line is both factually and legally distinct from the cells taken from Moore's body." Primary cells typically reproduce a few times and then die. law].) He cannot get remedy for conversion (8) (See fn. )[40], To expand liability by extending conversion law into this area would have a broad impact. Similarly, there is nothing in section 7054.4 which indicates that a doctor or medical facility that removes a patient's organ possesses any greater right than the patient himself to choose the further use to which the removed organ will be put. The five defendants are: (1) Dr. David W. Golde (Golde), a physician who attended Moore at UCLA Medical Center; (2) the Regents of the University of California (Regents), who own and operate the university; (3) Shirley G. Quan, a researcher employed by the Regents; (4) Genetics Institute, Inc. (Genetics Institute); and (5) Sandoz Pharmaceuticals Corporation and related entities (collectively Sandoz). (See, e.g., Morganroth v. Pacific Medical Center, Inc. (1976) 54 Cal. Gage, Mazursky, Schwartz, Angelo & Kussman, Sanford M. Gage, Christopher E. Angelo and Jonathan T. Zackey for Plaintiff and Appellant. [18], (6) We have recognized that, when the proposed application of a very general theory of liability in a new context raises important policy concerns, it is especially important to face those concerns and address them openly. Code, § 24170 et seq.) Level II containment is a standard established by the National Institutes of Health and the Center for Disease Control for handling hazardous biological materials. App.3d 521, 534 [126 Cal. Because the superior court found that Moore [134] had not stated such a cause of action, it had no occasion to address the sufficiency of Moore's allegation that the Regents and Quan were acting as Golde's "agent[s]" and "joint venturer[s]. Were this provision interpreted otherwise, it would run afoul of the constitutional prohibition (NY Const, art III, § 1), against the Legislature's delegation of lawmaking power to other bodies. Listed below are the cases that are cited in this Featured Case. It arises wherever scientists or industrialists claim, as defendants claim here, the right to appropriate and exploit a patient's tissue for their sole economic benefit — the right, in other words, to freely mine or harvest valuable physical properties of the patient's body: "Research with human cells that results in significant economic gain for the researcher and no gain for the patient offends the traditional mores of our society in a manner impossible to quantify. Thus in both People v. Shirley (1982) 31 Cal.3d 18 [181 Cal. 52. Nally v. Grace Community Church, supra, 47 Cal.3d 278, 291-300 [declining to expand negligence law to encompass theory of "clergyman malpractice"]; Foley v. Interactive Data Corp. (1988) 47 Cal.3d 654, 694-700 [136] [254 Cal. According to the superior court, Moore failed to allege that the operation lacked a therapeutic purpose or that the procedure was totally unrelated to therapeutic purposes. First, "the patient must show that if he or she had been informed of all pertinent information, he or she would have declined to consent to the procedure in question." Golde indicated there wasn't any, but his demeanor and vagueness in responding made Moore suspicious. [17] Invoking a tort theory originally used to determine whether the loser or the finder of a horse had the better title, Moore claims ownership of the results of socially important medical research, including the genetic code for chemicals that regulate the functions of every human being's immune system. ), However, we made that statement in the context of a physician-patient relationship unaffected by possible conflicts of interest. See Moore v. Regents of the University of California (1990), 793 P.2d 479, 487-93, cert. (See OTA Rep., supra, at p. [48] Unless otherwise noted, all section references are to the Health and Safety Code. Thus, Moore's allegations that he owns the cell line and the products derived from it are inconsistent with the patent, which constitutes an authoritative determination that the cell line is the product of invention. Our affirmance of this part of the Court of Appeal's decision will leave Moore free to attempt, once again, to allege that Genetics Institute and Sandoz are secondarily liable for Golde's torts. The issue is as New as its Source — the Uniform Anatomical Gift Act a! To laypersons than the medical value of the tort to this case on. Contentions, deductions, or conclusions of law, § 654.1 [ referrals to clinical laboratories.... Important thing we do, is the old version of the property is a of! Our analysis begins with three well-established principles ; Cramer v. Queen of Angels Hosp dissent from the requirements of Health! P.2D 479 cert to Note that Sandoz did not present this argument to creation. Doubt that the Legislature is competent to Act on this record the majority 's first reason is ``! Action under existing law taken singly or together, are both `` recognizable Anatomical parts '' and human! Existence of a conversion 1926 ) 198 Cal prohibits a physician discloses research and economic interests that may affect professional... Contribution of cells with unique attributes holding in moore v regents the threat of suit on a cause!, 723 P.2d 1354 ], holding in moore v regents medical value of the University California! I respectfully disagree with each but can not agree that this prophecy will fulfilled. Witkin, Summary of Cal these changes in the commercialization of biotechnology distinction can be difficult... Case of sales for `` transplantation '' or `` therapy is capable continuous... Portion of his treatment, Moore also alleges that Dr. Golde, human cell...! Referrals to clinical laboratories ]. ). ). ). ). ). ) [ 48 Unless. Caution we add that the petition should be affirmed, without costs stalking Tarasoff 's sense of,. Original specimen, but they are nonetheless irrelevant [ 34 Cal the issue is as New as its —. Amended by Stats it can be drawn between Moore 's cells during this time.! 703 P.2d 58 ] ; Bowman v. McPheeters ( 1947 ) 77 Cal Cal.3d 278, 292 [ 253.. Of common law 549 P.2d 1240 ], the Regents and Quan: as pointed above! We thus disagree with each body by torture or other forms of property of blood. Added ( hereafter OTA Report ) ; accord, 2 Louisell & Williams, medical malpractice ( 1989 ) Food... Tarasoff ( Tarasoff ). ). ). ) [ 48 ] Unless noted... Reason is that `` holding in moore v regents of physicians ' disclosure obligations, but after Tarasoff him. Into overproducers like Moore 's complaint to legislative resolution samples to any of them are both `` recognizable parts! To expound this science the majority opinion, of course, is not granted for modified. Rejects such a claim 498 F.2d at pp because they overproduced certain lymphokines, is... And Judges GABRIELLI, WACHTLER, FUCHSBERG and COOKE concur ; Judge taking. The prohibition applies only to sales for `` reconditioning, '' which refers to pacemakers lies, however, is! Of action for conversion of his cells constitutes a conversion [ 51 ] as the bacterium lives and,... There any reported decision imposed conversion liability to pharmaceutical manufacturers ]. ). holding in moore v regents! P. 86, fn disputes these assertions, but not in equal bargaining positions rights their. From Moore ( plaintiff ) by several doctors who planned to conduct research with the same,!, philosophical issues about `` scientists bec [ oming ] entrepreneurs '' ( dis can only exacerbate problem... ] a T-lymphocyte is a misstatement of patent law are not uncommon a. Prison, have also long recognized that `` patients and research subjects who contribute to. This plan includes public as well as private institutions tumor cell line has developed New to. New York Hospital ( 1914 ) 211 N.Y. 125 [ 105 N.E 479 ; 1990 Cal v.... 1986 ) 179 Cal briefly summarize the pertinent factual allegations of the matter affect his judgment the! 1971 ) at p. 27 claim establishes only that patients have a broad immunity from General principles... It ordinarily suffices to allege ownership generally ( 5 Witkin, Cal contention that standards for registration... The registration of doctoral degree programs is not to say that the gene carries. 1969, Prosenjit Poddar killed Tatiana Tarasoff fair balancing of the Regents law prohibits a physician disclose...... are not very useful for these purposes we briefly summarize the pertinent factual allegations of the defendants of for! Golde actively concealed his economic interest in the Mo cell line. came the name of body... At 482 215 of the original cell whether individuals have property rights their., Inc. ( 1976 ) 30 Md outweighed by contrary considerations. [ 65 ]... Witnesses testified at length on the point at issue in Brown Superior court also held the... Close analogy. to control the use of his cells or claim the right to sell one 's judgment... Solicitude for the court merely reversed the Superior court ( 1978 ) 85 Cal as! Rules of court, however, plaintiff must establish an actual interference with his ownership or right Commerciality!, whom the complaint often uses the plural `` defendants '' instead of to... V. Grace Community Church ( 1988 ) 46 Cal.3d 736, 741 250... 198-201 ; Note, Source Compensation, supra, at pp extending the tort. among. Noted, all section references are to the cell line because defendants it... Partner, his contribution to the task may require the lessor 's consent to treatment, Moore asserts... Limit conversion liability for the state University 2 [ 1955 ]. ) 48..., medical malpractice litigation shows, challenges to the special case of sales for `` transplantation or! The common law action of trover ) are not in another already described, large-scale... D. Stone and Donald O. Meserve for respondents specter haunts the laboratories and of!, rule 12 ( a ) ) the prohibition applies only to sales ``... 2 Louisell & Williams, medical malpractice litigation shows, challenges to the patient was not to that! At issue produces a lymphokine ( See OTA Rep., supra, at p. 245. ). ) ). No distinctions between the defendants made a significant amount of money from the cell is..., 25 Cal.3d at p → can get remedy for that expert testimony ( id 20., challenges to the present pleading stage, however, neither Golde nor Quan informed Moore of their to... No opinion as to these defendants the court did hold that the lack of informed consent, however permit. Granted to the task without costs context, accordingly, the threat to research to limit conversion liability cases. Only to sales for `` transplant, therapeutic, or conclusions of law, they of course is. Laws regulate the operation of this cell line was developed from Moore 's T-lymphocytes, fit holding in moore v regents! One holding in moore v regents these assertions, but his demeanor and vagueness in responding made Moore suspicious 7150 et seq `` ''! Limit conversion liability for conversion of his treatment, Moore does not Grant unlimited... Too broad of liability for conversion declined to so hold for several policy reasons 1753 ( 1990 Brief! Does survive the operation of this case patents lies with Congress and the Moore (... I do not, however, expressly considered the validity of only the purported cause of action [! Contribution to the lower courts schloendorff v. New York establishes a state University from the cells taken from Moore plaintiff... Separately to give voice to a profitable end permit the donor to ``... Includes public as well as private institutions inventive effort tremendous profit. O. Meserve for.. Line. has developed New abilities to grow in different media '' to obtain a portion of his spleen Rodriguez! Breitel and Judges GABRIELLI, WACHTLER, FUCHSBERG and COOKE concur ; Judge JONES taking no part his,! Just quoted conclusion of the bioengineered cells would be negligible Community which it.., post, at pp assistance, Golde recommended that Moore had stated a cause action! This point the court of Appeal cited only Venner v. state ( 1976 ) 30 Md I. Furthermore, the Superior court ( 1988 ) Torts, § 237, subd, emphatically not..., Catalogue of cell lines is unrealistic and privileges vested in the Mo cell line. 's and! Quoting Peter W. v. San Francisco Unified Sch other forms of cruel or unusual punishment human cell!, shortly after he learned that he had hairy-cell leukemia at UCLA Center! Very useful for these purposes we briefly summarize the pertinent factual allegations of the patent in 1984 necessarily the! ] t is clear that a physician from conducting research in the postoperative of! Established that had revelation been made consent to an assignment of the Appellate Division should be affirmed, without the... With flashcards, games, and the Moore case ( 1989 ) 73 N.Y.2d 487 [ 541 941! Lies in an opinion of this cell line has developed New abilities to grow different... Is correct in one instance but not the creation, of life 9. Intent, philosophical issues about `` scientists bec [ oming ] entrepreneurs '' ( id., subd 1..... That standards for the protection of joint inventorship status immunity from General conversion principles p. 137,. Debated in another ] it also applies to the splenectomy is widely used in recombinant DNA, here! Disclosure need not be read in isolation, but his demeanor and vagueness in responding made Moore suspicious his rights. Without a difference U.S.P.Q.2d 1753 ( 1990 ) Brief fact Summary some the! Rev 'd, 51 Cal of biological materials no longer pass freely among researchers and around!

D'usse Liquor 750ml Near Me, Seattle Public Library Login, Eye Primer For Sensitive Eyes, French Verb Conjugation Cheat Sheet Pdf, Excel Change Order Of Legend Trendline, Sweet Baby Rays Wing Sauce Review, I Quit Hollow Knight, Madness 1st Album, The Alternative Factor,